BRPI0410710A - compositions and methods comprising gastrin compounds and their uses - Google Patents
compositions and methods comprising gastrin compounds and their usesInfo
- Publication number
- BRPI0410710A BRPI0410710A BRPI0410710-1A BRPI0410710A BRPI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- gastrin compounds
- compounds
- beneficial effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
"COMPOSIçõES E MéTODOS QUE COMPREENDEM COMPOSTOS DE GASTRINA E SEUS USOS". A presente invenção se refere em geral a novas composições e métodos que compreendem um composto de gastrina. As composições e métodos proporcionam efeitos benéficos em particular efeitos benéficos sustentados no tratamento da diabetes."COMPOSITIONS AND METHODS UNDERSTANDING GASTRINE COMPOUNDS AND THEIR USES". The present invention generally relates to novel compositions and methods comprising a gastrin compound. The compositions and methods provide beneficial effects in particular sustained beneficial effects in the treatment of diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/016660 WO2003100024A2 (en) | 2002-05-24 | 2003-05-27 | Treatment for diabetes |
PCT/CA2004/000769 WO2004105780A2 (en) | 2003-05-27 | 2004-05-27 | Compositions comprising gastrin compounds and their use in diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0410710A true BRPI0410710A (en) | 2006-06-13 |
Family
ID=33488788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0410710-1A BRPI0410710A (en) | 2003-05-27 | 2004-05-27 | compositions and methods comprising gastrin compounds and their uses |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1648495A2 (en) |
JP (1) | JP2007513059A (en) |
CN (1) | CN1829528A (en) |
AU (1) | AU2004243541A1 (en) |
BR (1) | BRPI0410710A (en) |
CA (1) | CA2527186A1 (en) |
MX (1) | MXPA05012605A (en) |
NO (1) | NO20055582L (en) |
PL (1) | PL379145A1 (en) |
RU (1) | RU2005140518A (en) |
WO (1) | WO2004105780A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1486204A (en) | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | Compositions for inducing islet neogenesis, containing gastrin/CCK receptor ligands and egf receptor ligands |
EP1837031B1 (en) | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
JP2005533775A (en) | 2002-06-07 | 2005-11-10 | ワラタ ファーマシューティカルズ, インコーポレイテッド | Compositions and methods for treating diabetes |
RU2006131046A (en) * | 2004-01-30 | 2008-03-10 | Уэрейта Фармасьютикалз, Инк. (Ca) | JOINT USE OF GLP-1 AGONIST AND GASTRIN COMPOUNDS |
WO2008106779A1 (en) * | 2007-03-02 | 2008-09-12 | Waratah Pharmaceuticals Inc. | Gastrin compound for diabetes treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
DE69431212T2 (en) * | 1994-01-24 | 2003-04-10 | Waratah Pharmaceuticals Inc | TREATMENT OF DIABETES |
CN1486204A (en) * | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | Compositions for inducing islet neogenesis, containing gastrin/CCK receptor ligands and egf receptor ligands |
MXPA05004202A (en) * | 2002-10-22 | 2005-09-20 | Waratah Pharmaceuticals Inc | Treatment of diabetes. |
-
2004
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/en active Pending
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/en active Application Filing
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/en not_active IP Right Cessation
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
- 2004-05-27 EP EP04737749A patent/EP1648495A2/en not_active Withdrawn
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/en active Pending
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/en not_active Application Discontinuation
- 2004-05-27 CA CA002527186A patent/CA2527186A1/en not_active Abandoned
- 2004-05-27 PL PL379145A patent/PL379145A1/en not_active Application Discontinuation
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/en not_active Application Discontinuation
-
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL379145A1 (en) | 2006-07-24 |
WO2004105780A3 (en) | 2005-01-20 |
AU2004243541A1 (en) | 2004-12-09 |
CN1829528A (en) | 2006-09-06 |
RU2005140518A (en) | 2007-07-10 |
JP2007513059A (en) | 2007-05-24 |
MXPA05012605A (en) | 2006-02-22 |
CA2527186A1 (en) | 2004-12-09 |
NO20055582L (en) | 2006-02-27 |
NO20055582D0 (en) | 2005-11-25 |
WO2004105780A2 (en) | 2004-12-09 |
EP1648495A2 (en) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0307960A (en) | N-aminoacetyl pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors | |
SE0001899D0 (en) | New compounds | |
CR20150097A (en) | IMMUNOGENIC COMPOSITION | |
ECSP045429A (en) | COMBINATION OF ORGANIC COMPOUNDS | |
BRPI0513184A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation and application thereof in therapy | |
BR0316350A (en) | Diaminotriazoles useful as protein kinase inhibitors | |
BRPI0412689A (en) | heteroaryl and fused aryl derivatives as metabolism modulators and the prophylaxis and treatment of related disorders | |
BRPI0411862A (en) | combinations of active substances with insecticidal and acaricidal properties | |
BR0316609A (en) | Synomenin and synomenin compounds, synthesis and use | |
ECSP088152A (en) | 7-AZA-SUBSTITUTED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE | |
BR0214343A (en) | 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1 | |
BRPI0407139A (en) | Tri (Cycle) Replaced Amide Compounds | |
NO20064186L (en) | Substituted pyrazoline compositions to reduce blood triglycerides | |
BRPI0515316A (en) | imidazoquinoline compounds | |
SV1999000118A (en) | NEW SUBSTITUTED PIRAZOL DERIVATIVES REF. READ 33188-SV | |
ECSP10010735A (en) | CHEMICAL COMPOUNDS 251 | |
IS2517B (en) | Use of substituted 2-aminotetralins in the prevention of Parkinson's disease | |
BRPI0517846A (en) | azaindolcarboxamides | |
PL1809288T3 (en) | Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases | |
ECSP088252A (en) | 7-AZA-SUBSTITUTED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE | |
ATE516339T1 (en) | USE OF ISOMERS OF BICYCLOÄ2.2.1ÜHEPT-5-EN-2-CARBONIC ACID, ETHYLESTERS IN PERFUME COMPOSITIONS, AS WELL AS PERFUME COMPOSITIONS | |
BRPI0408685A (en) | detergent compositions | |
HK1083348A1 (en) | Perfuming ingredients of the woody type | |
BRPI0410710A (en) | compositions and methods comprising gastrin compounds and their uses | |
BRPI0519819A2 (en) | aqueous fabric softening composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |